Previous GLP-1 users were far more divided, with 52.34% trusting injections more and 43.75% trusting tablets more, suggesting confidence in tablets may grow once people move away from injectable treatment
Tirzepatide was initiated at a dose of 2.5 mg once weekly (or matching placebo) and was increased by 2.5 mg every 4 weeks during the dose-escalation period to reach a maintenance dose of up to 15 mg once weekly by week 20
While GLP 1 & GIP weight loss medications help you eat fewer calories, the use of peptides can help improve your metabolism and maintain important muscle mass
[2] Elokda AS, Nielsen DH
Malempati S, Weigel B, Ingle AM, Ahern CH, Carroll JM, Roberts CT, et al